PATH strives for vaccine equity in response to COVID-19

Related program: Center for Vaccine Innovation and Access

When COVID-19 emerged, we mobilized quickly and deployed our decades of experience advancing equitable access to vaccines and immunization to support the global COVID-19 response.

Through the PATH Center for Vaccine Innovation and Access (CVIA), our COVID-19 work spans the full vaccine development to delivery spectrum, including supporting country vaccine readiness; COVAX and other efforts to ensure equitable access to vaccine; vaccine development and manufacturing scale-up; vaccine clinical evaluation; immunization system resiliency; and other efforts.